783 related articles for article (PubMed ID: 28137310)
1. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
2. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
4. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
7. Lower Serum Levels of miR-29c-3p and miR-19b-3p as Biomarkers for Alzheimer's Disease.
Wu Y; Xu J; Xu J; Cheng J; Jiao D; Zhou C; Dai Y; Chen Q
Tohoku J Exp Med; 2017 Jun; 242(2):129-136. PubMed ID: 28626163
[TBL] [Abstract][Full Text] [Related]
8. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
11. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liang S; Xue J; Yao F; Liu X; Li F; Liu H; Sun L; Zhao K
Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
[TBL] [Abstract][Full Text] [Related]
12. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.
Piscopo P; Grasso M; Puopolo M; D'Acunto E; Talarico G; Crestini A; Gasparini M; Campopiano R; Gambardella S; Castellano AE; Bruno G; Denti MA; Confaloni A
J Alzheimers Dis; 2018; 65(2):455-464. PubMed ID: 30056425
[TBL] [Abstract][Full Text] [Related]
14. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
Jia LH; Liu YN
Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
18. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Validation of Circulating Hsa-miR-210-3p as a Potential Biomarker for Primary Open-Angle Glaucoma.
Liu Y; Wang Y; Chen Y; Fang X; Wen T; Xiao M; Chen S; Zhang X
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2925-2934. PubMed ID: 31284309
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNA biomarkers for Alzheimer's disease.
Kumar P; Dezso Z; MacKenzie C; Oestreicher J; Agoulnik S; Byrne M; Bernier F; Yanagimachi M; Aoshima K; Oda Y
PLoS One; 2013; 8(7):e69807. PubMed ID: 23922807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
